Dentsply International reported $1.21B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
3M USD 11.38B 2.35B Jun/2026
Agilent USD 2.27B 35M Mar/2026
Align Technology USD 1.91B 2.74M Jun/2026
Bruker USD 1.2B 150.4M Jun/2026
Cardinal Health USD 41.99B 1.33B Mar/2026
Charles River Laboratories USD 1.09B 26.61M Mar/2026
Cooper Companies USD 1.8B 209M Mar/2026
CVS Health USD 86.41B 2.29B Mar/2026
Danaher USD 8.1B 645M Jun/2026
Dentsply International USD 1.21B 136M Mar/2026
Henry Schein USD 3.49B 191M Jun/2026
Idexx Laboratories USD 1.29B 12.19M Jun/2026
Illumina USD 1.58B 12M Jun/2026
Integra LifeSciences USD 330.88M 15.96M Jun/2026
Intuitive Surgical USD 2.58B 65.1M Jun/2026
IQVIA Holdings USD 8.82B 486M Jun/2026
McKesson USD 67.02B 1.11B Mar/2026
Medtronic USD 9.5B 440M Dec/2025
Mettler Toledo International USD 1.2B 92.14M Jun/2026
Owens Minor USD 1.2B 256.03M Mar/2026
Repligen USD 132.66M 6.45M Jun/2026
Revvity USD 1.28B 37.71M Jun/2026
Smith & Nephew USD 2.05B 510M Jun/2026
Stryker USD 6.68B 369M Jun/2026
Thermo Fisher Scientific USD 15.07B 448M Jun/2026
Veradigm USD 230.31M 22.78M Dec/2022
Waters USD 2.27B 1.03B Mar/2026
Zimmer Biomet Holdings USD 2.86B 280.6M Mar/2026
Zoetis USD 2.05B 182M Mar/2026